8 completed. 8 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 8 |
| Phase 2 | 2 | Completed 2 |
Follow BPGbio: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety Study of Orally Administered BPM31510 in Healthy Subjects BPM31510 Oral Nanosuspension 4% - Healthy | Phase 1 | Completed | BPGbio | 25 | 2017-01-01 | 2017-04-05 |
| Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa topical BPM31510 3.0% Cream - Epidermolysis Bullosa | Phase 1 | Completed | Shasa Hu | 11 | 2016-08-10 | 2020-06-16 |
| A Safety Study of Orally Administered BPM31510 in Healthy Subjects BPM31510 Oral Nanosuspension 4% - Healthy | Phase 1 | Completed | BPGbio | 20 | 2015-11-01 | 2016-12-22 |
| BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors BP31510 monotherapy, BP31510 in combination with chemotherapy - Metastatic Cancer, Cancer | Phase 1 | Completed | BPGbio | 97 | 2013-10-01 | 2025-02-19 |
| Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for the Treatment of Chemotherapy-Induced Alopecia Compound 31543 Calcitriol 5 μg/mL, Compound 31543 Calcitriol 10 μg/mL, Compound 31543 Calcitriol 20 μg/mL - Chemotherapy-Induced Alopecia | Phase 1 | Completed | BPGbio | 28 | 2012-09-17 | 2026-08-17 |
| Safety Study of Sterile Compound C31510 for Injection to Subjects With Solid Tumors Sterile Compound C31510 for Injection - Solid Tumors | Phase 1 | Completed | BPGbio | 50 | 2011-01-01 | 2025-02-19 |
| An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS) API 31510 - Squamous Cell Carcinoma | Phase 1 / Phase 2 | Completed | BPGbio | 35 | 2008-06-01 | 2019-03-05 |
| Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma API 31510 3% Topical Cream, API 31510 1.5% Topical Cream, Placebo - Superficial Basal Cell Carcinoma | Phase 1 / Phase 2 | Completed | BPGbio | 186 | 2008-03-01 | 2025-02-28 |
Alopecia (1) · Brain Neoplasms (1) · Carcinoma, Squamous Cell (1) · Epidermolysis Bullosa (1) · Lymphoma (1) · Neoplasm Metastasis (1) · Neoplasms (1)
coenzyme Q10 (2) · Calcitriol (1) · Drug Therapy (1) · Injections (1)
United States (8)
Magdy Shenouda, MD (2) · David Wilson, MD (1) · Kim-Son Nguyen, MD (1) · Manish A Shah, MD (1) · Mario E Lacouture, MD (1) · Monica Mita, MD (1) · Shari Goldfarb, MD (1) · Vivek Subbiah, MD (1)